2,2,3,3,9,9,10,10-OCTAMETHYL-4,8-DIOXA-3,9-DISILAUNDECAN-6-OL, 90.0%, 5g

N,N-Dimethyl-m-anisidine>97.0%(GC)(T)25mL

4-Chloro-6-(trifluoromethyl)nicotinaldehyde, 97%, 250mg

1-Methyl-4-(1,4'-bipiperidin-4-yl)piperazine, 95%, 5g

2-(4-(tert-Butoxycarbonyl)-1,4-diazepan-1-yl)-2-(thiophen-3-yl)acetic acid, 96%, 5g

1-(2-Bromoethyl)-2-(trifluoromethyl)benzene, 97%, 1g

ERUCIC ACID ETHYL ESTER, 95%, 25g

(S)-7-Amino-5-methyl-5H-dibenzo[b,d]azepin-6(7H)-one hydrochloride, 95%, 25mg

(R)-3-(tert-Butoxy)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 100g

2-Methoxy-1-phenylethanone, 95.0%, 5g

2-(2-(Difluoromethoxy)-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 1g

2-Chloro-N-(thiophen-2-ylmethyl)quinazolin-4-amine, 95.0%, 5g

trans-4-(Trifluoromethyl)cyclohexanecarboxylic acid, 95.0%, 250mg